The kind and severity of infectious diseases, the host, the accessibility of drugs and the resistance patterns of causative microbes are the main drivers for the modern use of antibiotics. Although advances in rapid etiological diagnosis, clinical severity indexes and susceptibility/resistance profiles have been made, major deficiencies still exist in vaccination and other preventive measures, immediate bedside diagnosis, preservation of host defenses and other functions, universal availability of quality antimicrobials, appropriate use of currently available antibiotics and development of newer, more active ones. Research is required in all those areas as well as in veterinary medicine and agriculture to determine the exact contribution that each sector provides to the development of antimicrobial resistance. A global strategy for the optimal use of these apparently non-renewable resources may be drafted now, but implementation will need a concerted global effort that extends beyond the practice of medicine. 
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